Werewolf Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $1,143 | $742 | $1,501 |
Gross Profit | 689 | 278 | 1,041 |
EBITDA | -15,653 | -14,726 | -10,304 |
EBIT | -16,107 | -15,190 | -10,764 |
Net Income | -17,249 | -16,193 | -12,003 |
Net Change In Cash | 1,143 | 742 | 1,501 |
Free Cash Flow | -14,194 | -15,408 | -4,783 |
Cash | 135,303 | 139,189 | 134,343 |
Basic Shares | 43,521 | 41,607 | 36,570 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $19,943 | $16,401 | $4,148 | $0 |
Gross Profit | -18,963 | 16,401 | -735 | -777 |
EBITDA | -32,465 | -54,952 | -49,871 | -14,263 |
EBIT | -34,229 | -56,056 | -50,087 | -15,040 |
Net Income | -37,368 | -51,564 | -49,767 | -14,939 |
Net Change In Cash | 19,943 | 16,401 | 4,148 | 0 |
Cost of Revenue | -28,301 | 66,053 | ||
Free Cash Flow | -33,381 | -44,207 | -43,374 | -19,184 |
Cash | 134,343 | 129,315 | 157,531 | 92,570 |
Basic Shares | 35,646 | 28,864 | 27,313 | 28,664 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.38 |
2024-06-30 | -$0.38 |
2024-03-31 | -$0.39 |
2023-12-31 | -$0.33 |
